New study aims to predict liver failure and cancer before they happen

NCT ID NCT06523608

First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 28 times

Summary

This study is testing two new scoring methods (PLEASE and M10S20) to predict serious liver problems like liver failure or liver cancer in 600 people with advanced chronic liver disease. Participants are split into two groups: one gets standard check-ups every 6 months, while the other gets a personalized schedule based on their risk level. The goal is to see if these algorithms can catch problems earlier and improve survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Muenster

    RECRUITING

    Münster, North Rhine-Westphalia, 48149, Germany

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.